Heitersheim, Germany

Heribert Hellstern

USPTO Granted Patents = 10 


Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2009-2016

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Heribert Hellstern: Innovator in Macrocyclic Depsipeptides

Introduction

Heribert Hellstern is a notable inventor based in Heitersheim, Germany, recognized for his significant contributions to the field of chemical manufacturing. With a remarkable portfolio of ten patents, Hellstern has made strides particularly in the development of macrocyclic depsipeptides, which hold potential in various applications within medicinal chemistry.

Latest Patents

Among his latest inventions, Hellstern has focused on solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates. One patent outlines a method for the chemical manufacture of depsipeptides characterized by specific formulae and symbols defined in the detailed description. Another similar patent further explores these processes, enhancing the efficiency and effectiveness of producing these complex compounds.

Career Highlights

Heribert Hellstern is currently associated with Novartis AG, where he utilizes his expertise to drive innovation in pharmaceutical development. His work has resulted in a series of patents that not only advance scientific knowledge but also contribute to the broader field of drug discovery and development.

Collaborations

In his career, Hellstern has collaborated with distinguished colleagues such as Bernhard Wietfeld and Murat Acemoglu. These collaborations demonstrate a team-oriented approach, leading to innovative solutions and enhancing the impact of his inventions within the industry.

Conclusion

Through his inventive spirit and commitment to advancing chemical manufacturing processes, Heribert Hellstern continues to be a key figure in the development of macrocyclic depsipeptides. His contributions, backed by a solid foundation of patents, are paving the way for future advancements in the pharmaceutical domain.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…